secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0000064803-23-000003
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

CVS reaffirms FY2022 Adj. EPS guidance at high end; FY2023 Adj. EPS $8.70-$8.90
-------------------------------------------------------------------------------

- Reaffirmed FY2022 Adj. EPS guidance $8.55-$8.65; expects high end on lower share count.
- Expects to exceed FY2022 revenue guidance of $309B-$314B.
- Reaffirmed FY2023 Adj. EPS guidance $8.70-$8.90, excluding Signify Health acquisition.
- Repurchased ~15M shares in Q4 2022 at avg $99.99; entered $2B ASR effective Jan 3, 2023.
- MA membership growth low-to-mid-single digit % in 2023; individual MA below expectations, exchange memberships >750k.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480323000003/0000064803-23-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480323000003/cvs-20230109.htm
  HTML page:      https://secwatch.observer/filing/0000064803-23-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer